How big is the Asia-Pacific CDMO Market?

The Asia-Pacific CDMO Market size is expected to reach USD 71.60 billion in 2024 and grow at a CAGR of 8.60% to reach USD 108.17 billion by 2029. Read More

What is the current Asia-Pacific CDMO Market size?

In 2024, the Asia-Pacific CDMO Market size is expected to reach USD 71.60 billion. Read More

Who are the key players in Asia-Pacific CDMO Market?

Samsung Biologics, Jubilant Biosys Ltd, WuXi Biologics, Boehringer Ingelheim Group and Jubilant Biosys Ltd are the major companies operating in the Asia-Pacific CDMO Market. Read More

What years does this Asia-Pacific CDMO Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific CDMO Market size was estimated at USD 65.44 billion. The report covers the Asia-Pacific CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific CDMO Companies - Top Company List

Asia-Pacific CDMO Companies

This report lists the top Asia-Pacific CDMO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia-Pacific CDMO industry.